肿瘤营养学杂志（英文）（Journal of Nutritional Oncology）（不收版面费审稿费） （官网投稿）

万维提示：

1、投稿方式：在线投稿。

2、刊内网址（202504期）：

https://journals.lww.com/jno

3、投稿系统：

https://www.editorialmanager.com/jnutroncol

4、刊内邮箱：jno@nutroncol.org

5、刊内电话：010-63926987；0771-5358436

6、出刊日期：季刊，逢季中月15日出版。

7、官方微信公众号：JNO肿瘤营养学

8、官网信息：不收版面费审稿费。

2026年1月9日星期五

Instruction For Authors

【官网信息】

The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.

Editorial Office contact:

• Contact Email:  jno@nutroncol.org

AIMS AND SCOPE

The Journal of Nutritional Oncology (JNO) is an international, open-access, peer-reviewed academic journal that aims to reflect the latest findings in basic, clinical, and translation research in cancer metabolism, nutrition, and nutritional intervention. It publishes edge-cutting scientific studies in the field. It reports recent development and advances to its audience.

First launched in 2016, JNO strives to encourage studies and progress in nutritional oncology, as the role of nutrition in cancer prevention and treatment draws an increasing spotlight.

The scope of the Journal is but not limited to the following:

-Study on cancer-related metabolism and nutrition

-Basic studies on cancer, including etiology, pathogenesis, pathophysiology, and prevention strategies;

-Prevention, diagnosis, treatment, rehabilitation, and chronic disease management of nutritionally related diseases;

-Studies on public health related to epidemiology, prevention, monitoring, and health policy of nutritionally related diseases;

-Translational science related to nutritional oncology;

-Interdisciplinary research focusing on nutritional oncology.

ONLINE SUBMISSION

First-time Users

Please click the Register button at https://www.editorialmanager.com/jnutroncol/default2.aspx. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference.

Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.

Authors

Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.

JOURNAL POLICIES

Duplicate Publication

Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the JNO and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in the JNO to plagiarism-detection software.

This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.

Authorship

JNO expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.

Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author's specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:

Participated in research design

Participated in the writing or critical revision of the paper

Participated in the performance of the research

Contributed new reagents or analytic tools

Participated in data analysis

An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.

An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.

Plagiarism

As defined by the World Association of Medical Editors (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals), plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).

JNO is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com.

All allegations of plagiarism are investigated in accordance with the Committee on Publication Ethics (COPE) guidelines detailed at https://publicationethics.org/files/u7140/plagiarism%20A.pdf. When plagiarism is detected at any time before or after publication, the journal editorial office will take appropriate action as directed by the standards set forth by COPE. If plagiarism is found, the author, the author's institution and funding agencies, and the original publication will be notified. A statement noting the plagiarism, providing a reference to the plagiarized material, and linking to the original paper may follow. Depending on the extent of the plagiarism, the paper may also be formally retracted. For additional information, please visit http://www.publicationethics.org.

Financial Support and Disclosure of Conflicts

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript.

All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Competing interests" and “Funding".

For example: “Competing interests: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared."

“Funding": list all the grant supports/funders for the study.

A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.

The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link: https://www.icmje.org/disclosure-of-interest/.

Ethics

When reporting studies on human subjects, author should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki/). For prospective studies involving human participants, authors are expected to mention about approval of regional/national/institutional or independent ethics committee or review board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on the care and use of laboratory animals was followed.

Evidence for approval by a local ethics committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the ARRIVE and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving experimental animals and human beings, respectively. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the “Methods" section.

We reserve the right to decline publication of a paper even after it has been accepted if it becomes apparent that there are serious problems with the scientific content or violations of our publishing policies.

Studies in Humans and Animals

If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.

......

https://journals.lww.com/jno/Pages/instructionsforauthors.aspx